MedPath

Multiple Ascending Dose Study of BMS-582949 in Patients With Stable Rheumatoid Arthritis on the Methotrexate Background

Phase 1
Completed
Conditions
Rheumatoid Arthritis
Registration Number
NCT00162292
Lead Sponsor
Bristol-Myers Squibb
Brief Summary

The purpose of this clinical research study is to learn if it is safe for rheumatoid arthritis patients to take BMS-582949 along with methotrexate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria
  • Age 18-70 years
  • Diagnosis of RA for β‰₯6 months
  • Swollen or tender joint or ESR >ULN. Subject must be on stable doses of MTX
  • Women of Childbearing Potential
Exclusion Criteria
  • Serum transaminase levels >ULN
  • CK>ULN
  • Cannot have taken Orencia or Remicade within 8 weeks of baseline, Humira or Enbrel within 4 weeks of baseline
  • Use of H2 blockers or Proton Pump inhibitors while on study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
To evaluate safety and tolerability of BMS-582949 in subjects with active rheumatoid arthritis receiving concomitant MTX at steady stateduring 28 doses of treatment
Secondary Outcome Measures
NameTimeMethod
To evaluate the PK of BMS-582949 in clinically stable RA subjects on stable doses of MTX and concomitant BMS-582949
To explore DAS28, ESR, RF and CRP of clinically stable doses of MTX and concomitant BMS-582949 compared to MTX aloneduring 28 days of treatment
To evaluate PK of MTX in stable RA subjects in the absence and presence of BMS-582949 for subjects enrolled prior to approval of amendment 2

Trial Locations

Locations (9)

Local Institution

πŸ‡²πŸ‡½

Leon, Guanajuato, Mexico

Delray Research Associates

πŸ‡ΊπŸ‡Έ

Delray Beach, Florida, United States

Phase Iii Clinical Research

πŸ‡ΊπŸ‡Έ

Fall River, Massachusetts, United States

Boling Clinical Trials

πŸ‡ΊπŸ‡Έ

Upland, California, United States

Ocala Rheumatology Research Center

πŸ‡ΊπŸ‡Έ

Ocala, Florida, United States

Covance Clinical Research Unit Inc.

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Radiant Research San Antonio Northeast

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

Desert Medical Advances

πŸ‡ΊπŸ‡Έ

Palm Desert, California, United States

Healthcare Discoveries, Inc

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

Β© Copyright 2025. All Rights Reserved by MedPath